Precise mechanistic studies have shown that CXCL17 is associated with increased intratumoral infiltration of MDSCs, TAMs, and Tregs that mediate tumor immunosuppression, while decreasing CD4+ and CD8+ T cells with antitumor properties [27, 49]. The gene discussed is CXCL17; the disease is neoplasm.